The U.S. government said on Wednesday it will consider opportunities to "bring greater transparency" for the Medicare drug ...

A short statement from CMS said the agency will consider ways to make Medicare price negotiations, begun under Biden, more ...

The U.S. government said on Wednesday it will aim for "greater transparency" in Medicare drug price negotiations under ...

The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...

CMS said it is considering ways to bring "greater transparency" to the Medicare drug pricing negotiation program mandated ...

The US government said on Wednesday it will aim for "greater transparency" in Medicare drug price negotiations under ...

As the next round of Medicare drug pricing negotiations get underway, experts predict President Trump may seek to weaken the program.

Through the issuance of Inauguration Day executive orders, the Trump Administration signaled its apparent intent to tackle ...

An early move by the president has raised questions about what direction his second-term policy on drug costs will take.

President Donald Trump rescinded an executive order issued by former President Joe Biden aimed at finding new models for ...

Medicare beneficiaries may pay less for 15 additional prescription drugs as early as 2027 as part of the next round of federal regulators’ price negotiations with pharmaceutical manufacturers.

Medicare has undergone several major changes since it launched in 1965. And now, with the passage of the Inflation Reduction Act of 2022, it's poised to change again, with several key ...